| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
0-63 |
Sentence |
denotes |
MAFB as a novel regulator of human adipose tissue inflammation. |
| T1 |
0-63 |
Sentence |
denotes |
MAFB as a novel regulator of human adipose tissue inflammation. |
| T2 |
64-80 |
Sentence |
denotes |
AIMS/HYPOTHESIS: |
| T2 |
64-80 |
Sentence |
denotes |
AIMS/HYPOTHESIS: |
| T3 |
81-226 |
Sentence |
denotes |
Dysregulated expression of metabolic and inflammatory genes is a prominent consequence of obesity causing insulin resistance and type 2 diabetes. |
| T3 |
81-226 |
Sentence |
denotes |
Dysregulated expression of metabolic and inflammatory genes is a prominent consequence of obesity causing insulin resistance and type 2 diabetes. |
| T4 |
227-356 |
Sentence |
denotes |
Finding causative factors is essential to understanding progression of these pathologies and discovering new therapeutic targets. |
| T4 |
227-356 |
Sentence |
denotes |
Finding causative factors is essential to understanding progression of these pathologies and discovering new therapeutic targets. |
| T5 |
357-504 |
Sentence |
denotes |
The transcription factor V-maf musculoaponeurotic fibrosarcoma oncogene homologue B (MAFB) is highly expressed in human white adipose tissue (WAT). |
| T5 |
357-504 |
Sentence |
denotes |
The transcription factor V-maf musculoaponeurotic fibrosarcoma oncogene homologue B (MAFB) is highly expressed in human white adipose tissue (WAT). |
| T6 |
505-568 |
Sentence |
denotes |
However, its role in the regulation of WAT function is elusive. |
| T6 |
505-568 |
Sentence |
denotes |
However, its role in the regulation of WAT function is elusive. |
| T7 |
569-685 |
Sentence |
denotes |
We aimed to characterise MAFB expression and function in human WAT in the context of obesity and insulin resistance. |
| T7 |
569-685 |
Sentence |
denotes |
We aimed to characterise MAFB expression and function in human WAT in the context of obesity and insulin resistance. |
| T8 |
686-830 |
Sentence |
denotes |
METHODS: MAFB mRNA expression was evaluated in human WAT from seven cohorts with large inter-individual variation in BMI and metabolic features. |
| T8 |
686-830 |
Sentence |
denotes |
METHODS: MAFB mRNA expression was evaluated in human WAT from seven cohorts with large inter-individual variation in BMI and metabolic features. |
| T9 |
831-933 |
Sentence |
denotes |
Insulin-induced adipocyte lipogenesis and lipolysis were measured and correlated with MAFB expression. |
| T9 |
831-933 |
Sentence |
denotes |
Insulin-induced adipocyte lipogenesis and lipolysis were measured and correlated with MAFB expression. |
| T10 |
934-1043 |
Sentence |
denotes |
MAFB regulation during adipogenesis and the effects of MAFB suppression in human adipocytes was investigated. |
| T10 |
934-1043 |
Sentence |
denotes |
MAFB regulation during adipogenesis and the effects of MAFB suppression in human adipocytes was investigated. |
| T11 |
1044-1142 |
Sentence |
denotes |
MAFB regulation by TNF-α was examined in human primary adipocytes and THP-1 monocytes/macrophages. |
| T11 |
1044-1142 |
Sentence |
denotes |
MAFB regulation by TNF-α was examined in human primary adipocytes and THP-1 monocytes/macrophages. |
| T12 |
1143-1329 |
Sentence |
denotes |
RESULTS: MAFB expression in human adipocytes is upregulated during adipogenesis, increases with BMI in WAT, correlates with adverse metabolic features and is decreased after weight loss. |
| T12 |
1143-1329 |
Sentence |
denotes |
RESULTS: MAFB expression in human adipocytes is upregulated during adipogenesis, increases with BMI in WAT, correlates with adverse metabolic features and is decreased after weight loss. |
| T13 |
1330-1440 |
Sentence |
denotes |
MAFB downregulation decreases proinflammatory gene expression in adipocytes and interferes with TNF-α effects. |
| T13 |
1330-1440 |
Sentence |
denotes |
MAFB downregulation decreases proinflammatory gene expression in adipocytes and interferes with TNF-α effects. |
| T14 |
1441-1555 |
Sentence |
denotes |
Interestingly, MAFB is differentially regulated by TNF-α in adipocytes (suppressed) and THP-1 cells (upregulated). |
| T14 |
1441-1555 |
Sentence |
denotes |
Interestingly, MAFB is differentially regulated by TNF-α in adipocytes (suppressed) and THP-1 cells (upregulated). |
| T15 |
1556-1693 |
Sentence |
denotes |
Further, MAFB is primarily expressed in WAT macrophages/monocytes and its expression correlates with macrophage and inflammatory markers. |
| T15 |
1556-1693 |
Sentence |
denotes |
Further, MAFB is primarily expressed in WAT macrophages/monocytes and its expression correlates with macrophage and inflammatory markers. |
| T16 |
1694-1721 |
Sentence |
denotes |
CONCLUSIONS/INTERPRETATION: |
| T16 |
1694-1721 |
Sentence |
denotes |
CONCLUSIONS/INTERPRETATION: |
| T17 |
1722-1868 |
Sentence |
denotes |
Our findings indicate that MAFB is a regulator and a marker of adipose tissue inflammation, a process that subsequently causes insulin resistance. |
| T17 |
1722-1868 |
Sentence |
denotes |
Our findings indicate that MAFB is a regulator and a marker of adipose tissue inflammation, a process that subsequently causes insulin resistance. |